| Business Summary | | Boston
Scientific
Corporation
is
a
worldwide
developer,
manufacturer
and
marketer
of
less-invasive
medical
devices.
The
Company's
products
are
used
in
a
broad
range
of
interventional
medical
specialties,
including
interventional
cardiology,
electrophysiology,
gastroenterology,
neuro-endovascular
therapy,
pulmonary
medicine,
interventional
radiology,
oncology,
urology
and
vascular
surgery.
The
Company's
products
are
generally
inserted
into
the
human
body
through
natural
openings
or
small
incisions
in
the
skin,
and
can
be
guided
to
most
areas
of
the
anatomy
to
diagnose
and
treat
a
wide
range
of
medical
problems. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Boston
Scientific
Corp.
develops,
manufactures
and
markets
minimally
invasive
medical
devices
used
in
cardiology,
electrophysiology,
gastroenterology,
radiology,
urology
and
vascular
surgery.
For
the
six
months
ended
6/30/01,
net
sales
fell
4%
to
$1.33
billion.
Net
loss
totalled
$177
million,
vs.
income
of
$228
million.
Revenues
reflect
foreign
currency
fluctuations
and
lower
sales
of
coronary
stents
and
balloons.
Loss
reflects
higher
purchased
R&D
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Pete Nicholas, 59 Chairman | $1.2M | Lawrence Best, 50 CFO,
Sr. VP-Fin. and Admin. | 1.0M | James Tobin, 56 Director,
Pres and CEO | 1.2M | Kshitij Mohan, Ph.D., 55 Sr.
VP, CTO | -- | Paul Sandman, 53 Sr.
VP, Gen. Counsel, and Sec. | 960K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|